Sun Pharma Projects High Single-Digit Revenue Growth for FY25
Sun Pharmaceutical Industries, a leading Indian multinational pharmaceutical company, is expecting a…
Novo Nordisk CEO Outlines Strategy Amid Intensifying Competition in Obesity Drug Market
Novo Nordisk CEO Lars Fruergaard Jorgensen revealed the company's strategy for launching…
Wall Street Eyes Soaring Growth in 2024: 3 Stocks to Watch
As Wall Street prepares to bid farewell to a remarkable year, marked…
Pfizer’s Bleak 2024 Forecast Casts Shadow on Recovery Prospects Post-2023 Downturn
Introduction: Pfizer Inc. faces a challenging entry into the new year as…
Novo Nordisk Pledges $2.3 Billion Investment in French Site Amid High Demand for Ozempic
Novo Nordisk A/S, the maker of the popular weight-loss medication Ozempic, is…
Biotech Firm’s $15 Million Investment Transforms into $5 Billion with Roche Acquisition
In a remarkable turn of events, a biotech firm founded by Vivek…
